Switch to:
More From Other Websites
PROGENICS PHARMACEUTICALS INC Financials Aug 13 2016
Valeant’s Relistor Said to Draw Interest of Potential Buyers Aug 05 2016
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 04 2016
Progenics reports 2Q loss Aug 04 2016
Progenics reports 2Q loss Aug 04 2016
Progenics Pharmaceuticals Announces Second Quarter 2016 Financial and Business Results Aug 04 2016
Progenics Pharmaceuticals Announces Second Quarter 2016 Financial and Business Results Aug 04 2016
Biotech Week In Review: Valeant, Progenics, Relistor and Vesneo – Valeant Pharmaceuticals Intl Inc... Jul 29 2016
Progenics Receives $50 Million Milestone Payment Following FDA Approval of RELISTOR® Tablets for... Jul 26 2016
Progenics receives $50 mln milestone payment after opioid-induced constipation drug approval Jul 26 2016
Progenics Receives $50 Million Milestone Payment Following FDA Approval of RELISTOR® Tablets for... Jul 26 2016
Progenics Pharmaceuticals Sets Second Quarter 2016 Financial Results Call for August 4 Jul 22 2016
Progenics Pharmaceuticals Sets Second Quarter 2016 Financial Results Call for August 4 Jul 22 2016
ETF’s with exposure to Progenics Pharmaceuticals, Inc. : July 21, 2016 Jul 21 2016
Why Valeant, Progenics, Ryerson, Zafgen and TerraForm Are On The Move Today Jul 20 2016
These 3 Stocks Are Rising on Big Volume -- Is It Time to Buy? Jul 20 2016
Progenics (PGNX) Stock Soars as Relistor Receives FDA Approval Jul 20 2016
Valeant Pharmaceuticals: Two for Two Jul 20 2016
Valeant (VRX) Stock Gains as FDA Approves Anticonstipation Drug Jul 20 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK